Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ginkgo Bioworks Holdings Inc DNA

Alternate Symbol(s):  DNABW

Chemicals Specialty Chemicals
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration... see more

Recent & Breaking News (NYSE:DNA)

Thornton Law Firm Announces Investigation Into DNA

Newsfile October 7, 2021

EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Ginkgo Bioworks Holdings, Inc.

Newsfile October 7, 2021

Ginkgo Bioworks Investor Alert

Newsfile October 7, 2021

DNA Investigation Alert:  Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) Investors

Business Wire October 7, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Ginkgo Bioworks (DNA) Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations

PR Newswire October 7, 2021

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire October 7, 2021

Ademi LLP Investigates Claims of Securities Fraud against Ginkgo Bioworks Holdings, Inc.

PR Newswire October 6, 2021

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors

Business Wire October 6, 2021

SHAREHOLDER ALERT: Investigation of Ginkgo Bioworks Holdings, Inc. Announced by Holzer & Holzer, LLC

Newsfile October 6, 2021

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile October 6, 2021

EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Ginkgo Bioworks Holdings, Inc.

Newsfile October 6, 2021

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors

Business Wire October 6, 2021

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire October 6, 2021

DNA INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Ginkgo Bioworks Holdings, Inc. Investors with Losses to Inquire About Class Action Investigation - DNA

Business Wire October 6, 2021

Ginkgo Bioworks Announces Participation in Upcoming Conferences

PR Newswire September 30, 2021

Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds

PR Newswire September 17, 2021